CN1195767C - 抗血栓形成化合物 - Google Patents
抗血栓形成化合物 Download PDFInfo
- Publication number
- CN1195767C CN1195767C CNB008167753A CN00816775A CN1195767C CN 1195767 C CN1195767 C CN 1195767C CN B008167753 A CNB008167753 A CN B008167753A CN 00816775 A CN00816775 A CN 00816775A CN 1195767 C CN1195767 C CN 1195767C
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- solution
- spacer
- pentose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99204172 | 1999-12-07 | ||
EP99204172.3 | 1999-12-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1407989A CN1407989A (zh) | 2003-04-02 |
CN1195767C true CN1195767C (zh) | 2005-04-06 |
Family
ID=8240976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008167753A Expired - Fee Related CN1195767C (zh) | 1999-12-07 | 2000-12-01 | 抗血栓形成化合物 |
Country Status (23)
Country | Link |
---|---|
US (1) | US6875755B2 (zh) |
EP (1) | EP1237897B1 (zh) |
JP (1) | JP4820517B2 (zh) |
KR (1) | KR100776607B1 (zh) |
CN (1) | CN1195767C (zh) |
AR (1) | AR026726A1 (zh) |
AU (1) | AU781846B2 (zh) |
BR (1) | BR0016217A (zh) |
CA (1) | CA2393042C (zh) |
CO (1) | CO5251449A1 (zh) |
CZ (1) | CZ303385B6 (zh) |
HK (1) | HK1047593A1 (zh) |
HU (1) | HUP0203471A3 (zh) |
IL (2) | IL149628A0 (zh) |
NO (1) | NO323059B1 (zh) |
NZ (1) | NZ519100A (zh) |
PE (1) | PE20010935A1 (zh) |
PL (1) | PL202840B1 (zh) |
RU (1) | RU2266913C2 (zh) |
SK (1) | SK287682B6 (zh) |
TW (1) | TWI289566B (zh) |
WO (1) | WO2001042262A2 (zh) |
ZA (1) | ZA200203799B (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2806561C (en) * | 2001-09-07 | 2015-12-22 | Alchemia Limited | Synthetic heparin pentasaccharides |
WO2004007468A1 (en) | 2002-07-15 | 2004-01-22 | Merck & Co., Inc. | Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
AU2003275404A1 (en) | 2002-10-07 | 2004-05-04 | Merck & Co., Inc. | Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
PL376822A1 (pl) | 2002-11-07 | 2006-01-09 | Merck & Co., Inc. | Pochodne fenyloalaniny jako inhibitory dipeptydylopeptydazy do leczenia lub zapobiegania cukrzycy |
JP4564952B2 (ja) | 2003-01-17 | 2010-10-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての3−アミノ−4−フェニルブタン酸誘導体 |
US7388019B2 (en) | 2003-01-31 | 2008-06-17 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
EP1624874B1 (en) | 2003-05-14 | 2009-11-04 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
US7332520B2 (en) | 2003-06-06 | 2008-02-19 | Merck & Co., Inc. | Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
AU2004249163A1 (en) | 2003-06-17 | 2004-12-29 | Merck & Co., Inc. | Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
CA2533893A1 (en) | 2003-07-31 | 2005-02-10 | Merck & Co., Inc. | Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
EP1574516A1 (en) * | 2004-03-05 | 2005-09-14 | Sanofi-Aventis | Antithrombotic compound |
TW200621794A (en) * | 2004-10-06 | 2006-07-01 | Akzo Nobel Nv | Pulmonary administration of an antithrombotic compound |
TWI403334B (zh) * | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
TWI376234B (en) | 2005-02-01 | 2012-11-11 | Msd Oss Bv | Conjugates of a polypeptide and an oligosaccharide |
MY145269A (en) * | 2005-10-10 | 2012-01-13 | Organon Nv | Antithrombotic dual inhibitors comprising a biotin label |
WO2011073408A2 (en) | 2009-12-18 | 2011-06-23 | Endotis Pharma | Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4115468A1 (de) * | 1991-05-11 | 1992-11-12 | Behringwerke Ag | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien |
DE4206858A1 (de) * | 1992-03-05 | 1993-09-09 | Behringwerke Ag | Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel |
ATE190619T1 (de) * | 1993-09-01 | 2000-04-15 | Akzo Nobel Nv | Biskonjugate, die zwei saccharide und einen spacer enthalten |
IL126893A (en) * | 1997-11-19 | 2003-05-29 | Akzo Nobel Nv | Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them |
CA2334863C (en) * | 1998-06-17 | 2011-02-15 | Akzo Nobel Nv | Antithrombotic compounds |
-
2000
- 2000-11-21 TW TW089124693A patent/TWI289566B/zh not_active IP Right Cessation
- 2000-12-01 HU HU0203471A patent/HUP0203471A3/hu unknown
- 2000-12-01 IL IL14962800A patent/IL149628A0/xx unknown
- 2000-12-01 SK SK794-2002A patent/SK287682B6/sk not_active IP Right Cessation
- 2000-12-01 US US10/148,868 patent/US6875755B2/en not_active Expired - Lifetime
- 2000-12-01 NZ NZ519100A patent/NZ519100A/en not_active IP Right Cessation
- 2000-12-01 PL PL355484A patent/PL202840B1/pl not_active IP Right Cessation
- 2000-12-01 CN CNB008167753A patent/CN1195767C/zh not_active Expired - Fee Related
- 2000-12-01 BR BR0016217-5A patent/BR0016217A/pt active Search and Examination
- 2000-12-01 JP JP2001543559A patent/JP4820517B2/ja not_active Expired - Lifetime
- 2000-12-01 RU RU2002118117/04A patent/RU2266913C2/ru not_active IP Right Cessation
- 2000-12-01 WO PCT/EP2000/012155 patent/WO2001042262A2/en active Search and Examination
- 2000-12-01 EP EP00983209.8A patent/EP1237897B1/en not_active Expired - Lifetime
- 2000-12-01 CZ CZ20021958A patent/CZ303385B6/cs not_active IP Right Cessation
- 2000-12-01 CA CA2393042A patent/CA2393042C/en not_active Expired - Lifetime
- 2000-12-01 AU AU20038/01A patent/AU781846B2/en not_active Expired
- 2000-12-01 KR KR1020027007186A patent/KR100776607B1/ko not_active IP Right Cessation
- 2000-12-06 CO CO00093231A patent/CO5251449A1/es not_active Application Discontinuation
- 2000-12-06 AR ARP000106443A patent/AR026726A1/es active IP Right Grant
- 2000-12-06 PE PE2000001308A patent/PE20010935A1/es not_active Application Discontinuation
-
2002
- 2002-05-13 ZA ZA200203799A patent/ZA200203799B/xx unknown
- 2002-05-14 IL IL149628A patent/IL149628A/en not_active IP Right Cessation
- 2002-06-06 NO NO20022689A patent/NO323059B1/no not_active IP Right Cessation
- 2002-12-18 HK HK02109170.1A patent/HK1047593A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1195767C (zh) | 抗血栓形成化合物 | |
CN1191093C (zh) | Dds化合物及其测定方法 | |
CN1231675A (zh) | 修饰的生理活性蛋白及含有该蛋白的药物组合物 | |
CN1192216A (zh) | 用于治疗和预防内毒素血症的取代的脂多糖 | |
CN1261450C (zh) | 抗血栓形成化合物 | |
JP5632886B2 (ja) | ビオチン残基を含む抗血栓性デュアルインヒビター | |
CN101454309B (zh) | 焦谷氨酸衍生物的合成和用途 | |
CN1184483A (zh) | 岩藻肽 | |
CN1057772C (zh) | 治疗免疫调节的炎症的化合物和组合物 | |
CN1132755A (zh) | 七叶内酯衍生物及其制备方法和药物组合物 | |
RU2305679C2 (ru) | Пролекарства на основе d-пролина | |
CN1441784A (zh) | 含有氨基异喹啉基团的凝血酶抑制剂 | |
CN1518557A (zh) | 新颖5-硫-β-D-木糖吡喃糖苷衍生物,其制法,含该衍生物的医药组合物及其治疗用途 | |
JP4842254B2 (ja) | Par−2アゴニスト | |
MXPA02005278A (en) | Antithrombotic compound | |
CN107407673A (zh) | 新颖聚醣结合物及其使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SANOFI SYNTHESIZING LABORATORY Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20030812 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20030812 Address after: France Applicant after: Sanofi Synthesis Lab. Address before: Holland Arnhem Applicant before: Akzo Nobel N. V. |
|
ASS | Succession or assignment of patent right |
Owner name: AKZO NOVEL N.V. CORP. Free format text: FORMER OWNER: NONE Effective date: 20040514 Owner name: SANOFI SYNTHESIZING LABORATORY; Free format text: FORMER OWNER: SANOFI SYNTHESIZING LABORATORY |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20040514 Address after: France Applicant after: Sanofi Synthesis Lab. Co-applicant after: Akzo Nobel N. V. Address before: France Applicant before: Sanofi Synthesis Lab. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20050415 Owner name: AKZO NOVEL N.V. CORP. Free format text: FORMER OWNER: SANOFI SYNTHESIZING LABORATORY |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050415 Address after: Holland Arnhem Patentee after: Akzo Nobel N. V. Address before: France Co-patentee before: Akzo Nobel N. V. Patentee before: Sanofi Synthesis Lab. |
|
ASS | Succession or assignment of patent right |
Owner name: ORGANON NV Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20070105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070105 Address after: Holland Patentee after: Organon NV Address before: Holland Arnhem Patentee before: Akzo Nobel N. V. |
|
C56 | Change in the name or address of the patentee |
Owner name: MSD OS CO., LTD. Free format text: FORMER NAME: ORGANON NV |
|
CP01 | Change in the name or title of a patent holder |
Address after: Holland Patentee after: MSD Oss Bv Address before: Holland Patentee before: Organon NV |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050406 Termination date: 20131201 |